Articaine vs Lidocaine for Pediatric Dental Procedures

Sponsor
Boston University (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03318952
Collaborator
(none)
0
1
2
9
0

Study Details

Study Description

Brief Summary

The purpose of this study is to compare the efficacy of two types of local anesthesia (articaine and lidocaine) for infiltration anesthesia during restorative dental procedures on lower teeth in pediatric patients. The patients will require similar dental operative procedures on both right and left sides of the mandible in order to qualify for this study. The study will require at least two dental appointments, where a randomized, cross-over study methodology will be utilized. All subjects will be treated by the same dentist. The comfort of the patient will be assessed at various points during the procedure using the Wong-Baker Faces Scale.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

This study will compare articaine to lidocaine with overall quality of anesthesia. When administering lidocaine, the investigator will follow standard of care by administering a buccal infiltration injection followed by 2-3 interpapillary injections, one at each gingival papilla where the rubber dam clamp will be placed and possibly more if needed in areas where dental treatment will be provided. A single buccal infiltration injection of articaine will be administered, with the hypothesis that articaine is a stronger anesthestic and will deliver palatal anesthesia with a single injection, eliminating the interpapillary injections required for lidocaine to achieve adequate soft tissue anesthesia. The comfort of the patient during multiple steps of the dental treatment will be recorded. A randomized, cross-over methodology will be used. This study seeks to find whether adequate anesthesia in the mandible can be achieved with a single injection of articaine in the buccal aspect of the jaw instead of having to administer multiple injections of lidocaine, which can increase patient anxiety and discomfort. By decreasing the number of injections needed for children during dental treatment while providing adequate local anesthesia, dentists can provide more comfortable care to their pediatric patients.

Specific Aims/ Hypothesis

-Specific Aim 1: To compare articaine to lidocaine with achieving effective local anesthesia in the mandible and upper arch of pediatric dental patients.

Hypothesis: The solubility of articaine will provide more effective anesthetic delivery through the soft and hard tissue of the mandible following buccal infiltration, eliminating the need for multiple injections.

-Specific Aim 2: To identify which type of anesthetic provides the best patient experience by way of measuring patient comfort at various stages of the dental procedure.

Hypothesis: The patient will have an equally comfortable experience during the dental procedure when articaine or lidocaine is used.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Efficacy of Articaine vs. Lidocaine When Used for Local Infiltration in Pediatric Dental Procedures
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Jun 1, 2023
Anticipated Study Completion Date :
Jun 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: lidocaine then articaine

For the first dental procedure 2% lidocaine with 1:100,000 epinephrine will be administered with a buccal infiltration injection followed by 2-3 interpapillary injections and possibly more if needed. For the second dental procedure a single buccal infiltration injection of 4% articaine with 1:100,000 epinephrine will be administered.

Drug: lidocaine
A buccal infiltration injection followed by 2-3 interpapillary injections and possibly more if needed of 2% lidocaine with 1:100,000 epinephrine will be administered.

Drug: articaine
A single buccal infiltration injection of 4% articaine with 1:100,000 epinephrine will be administered

Experimental: articaine then lidocaine

For the first dental procedure a single buccal infiltration injection of 4% articaine with 1:100,000 epinephrine will be administered. For the second dental procedure 2% lidocaine with 1:100,000 epinephrine will be administered with a buccal infiltration injection followed by 2-3 interpapillary injections and possibly more if needed.

Drug: lidocaine
A buccal infiltration injection followed by 2-3 interpapillary injections and possibly more if needed of 2% lidocaine with 1:100,000 epinephrine will be administered.

Drug: articaine
A single buccal infiltration injection of 4% articaine with 1:100,000 epinephrine will be administered

Outcome Measures

Primary Outcome Measures

  1. Pain during anesthesia injection using the Wong-Baker faces scale [Anesthesia injection is usually about 10 min before the dental procedure starts.]

    Wong-Baker faces scale is a set of six cartoon faces with varying facial expressions ranging from a smile/laughter to tears. Each face has a numeric value with a range of 1 to 10. The higher the numeric value the more intense the pain.

  2. Pain during rubber dam placement using the Wong-Baker faces scale [Rubberdam placement is usually about 5 min before the dental procedure starts.]

    Wong-Baker faces scale is a set of six cartoon faces with varying facial expressions ranging from a smile/laughter to tears. Each face has a numeric value with a range of 1 to 10. The higher the numeric value the more intense the pain.

  3. Pain during tooth preparation using the Wong-Baker faces scale [Tooth preparation occurs during the dental procedure.]

    Wong-Baker faces scale is a set of six cartoon faces with varying facial expressions ranging from a smile/laughter to tears. Each face has a numeric value with a range of 1 to 10. The higher the numeric value the more intense the pain.

  4. Pain during pulp opening using the Wong-Baker faces scale [Pulp opening occurs during the dental procedure.]

    Wong-Baker faces scale is a set of six cartoon faces with varying facial expressions ranging from a smile/laughter to tears. Each face has a numeric value with a range of 1 to 10. The higher the numeric value the more intense the pain.

  5. Pain during restoration placement using the Wong-Baker faces scale [Restoration placement is at the end of the dental procedure, approximately 1 hour.]

    Wong-Baker faces scale is a set of six cartoon faces with varying facial expressions ranging from a smile/laughter to tears. Each face has a numeric value with a range of 1 to 10. The higher the numeric value the more intense the pain.

Secondary Outcome Measures

  1. Additional injections of local anesthetic at the first visit [At the completion of the first visit, approximately 1 hour.]

    The number of extra injections to achieve anesthesia will be documented for each participant.

  2. Additional injections of local anesthetic at the second visit [At the completion of the second visit, approximately 1 hour.]

    The number of extra injections to achieve anesthesia will be documented for each participant.

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Years to 14 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients receiving dental care at Boston Medical Center Pediatric Dental Clinic, Boston University Pediatric Oral Health Center, and East Boston Neighborhood Health Center Pediatric Dental Clinic

  • Patients needing similar restorative dental procedures to primary molar teeth on both sides of the maxillary arch or upper arch

  • Boys and girls between ages 4 to 14 years

  • English speaking and be able to understand verbal assent.

Exclusion Criteria:
  • Patients for whom the use of articaine is contraindicated such as patients with Acetylcholine esterase deficiency

  • Patients for whom the use of lidocaine is contraindicated in patients taking metronidazole

Contacts and Locations

Locations

Site City State Country Postal Code
1 BU Henry M. Goldman School of Dental Medicine Boston Massachusetts United States 02118

Sponsors and Collaborators

  • Boston University

Investigators

  • Principal Investigator: Jayapriyaa Shanmugham, BDS MPH DrPH, BU Henry M. Goldman School of Dental Medicine

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Boston University
ClinicalTrials.gov Identifier:
NCT03318952
Other Study ID Numbers:
  • H-33755
First Posted:
Oct 24, 2017
Last Update Posted:
Aug 16, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by Boston University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 16, 2022